https://heliovigil.com/wp-content/uploads/2020/08/floating_image_01.png
https://heliovigil.com/wp-content/uploads/2020/08/floating_image_02.png

Experts in Healthcare

https://heliovigil.com/wp-content/uploads/2020/08/floating_image_03.png

& Drug safety

At the heart of creating a healthier world lies our commitment to empower our customers and partners to achieve extraordinary feats in healthcare.
bt_bb_section_bottom_section_coverage_image
https://heliovigil.com/wp-content/uploads/2020/08/floating_image_04.png

Discover comprehensive healthcare solutions tailored to your company's unique needs.

As a young and innovative company, we bring fresh perspectives and cutting-edge solutions to transform your healthcare strategy.

We offer a comprehensive range of healthcare solutions to help you achieve your Healthcare goals. From pharmacovigilance and regulatory affairs support to medical information call center services and medical writing, our team of industry experts is dedicated to delivering exceptional results and unlocking new possibilities for your research. With our advanced technology solutions and commitment to collaboration, we are here to help you navigate the complex landscape of healthcare research and achieve success.

Pharmacovigilance
Regulatory Affairs Support
Medical Writing Services
Medical Transcription
Medical Scribing
Medical Information Call Center Services
Technology Solutions
bt_bb_section_bottom_section_coverage_image
https://heliovigil.com/wp-content/uploads/2020/08/floating_image_03.png
https://heliovigil.com/wp-content/uploads/2020/08/floating_image_05.png

Ignite Your Potential and Transform Healthcare for a Brighter Future.

Join our team of fearless innovators, dedicated to advancing human health through bold ideas and building upon past successes.
bt_bb_section_top_section_coverage_image
bt_bb_section_bottom_section_coverage_image
https://heliovigil.com/wp-content/uploads/2020/08/floating_image_04.png

RESOURCE HUB

Explore the latest Trends & News in Healthcare.
FDA Advisory No.2023-0771 || Adoption of the World Health Organization Updated Guidelines on the Evaluation of Similar Biotherapeutic Products (SBPs) in Compliance with Administrative Order No. 2014-0016
May 20, 2023
FDA Advisory No.2023-0771 || Adoption of the World Health Organization Updated Guidelines on the Evaluation of Similar Biotherapeutic Products (SBPs) in Compliance with Administrative Order No. 2014-0016
This is to inform concerned stakeholders of the compliance to Administrative Order (AO) No. 2014-0016 entitled Adoption of the World Health Organization, “Guidelines on Evaluation of Similar Biotherapeutic Products (SBPs)” for the Registration of Biosimilar Products which directs all manufacturers, traders and distributors (exporters, importer, wholesaler) of biosimilar products to adopt the current version of the WHO “Guidelines on Evaluation of Biosimilars” (2022).
Fluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling and potentially irreversible side effects
May 12, 2023
Fluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling and potentially irreversible side effects
Dynamically reinvent market-driven opportunities and ubiquitous interfaces. Energistically fabricate an array of niche markets through products. Objectively innovate empowered manufactured products whereas parallel platforms. Holisticly predominate extensible testing procedures.
Notify the MHRA about a clinical investigation for a medical device
May 9, 2023
Notify the MHRA about a clinical investigation for a medical device
Collaboratively administrate turnkey channels whereas virtual e-tailers. Objectively seize scalable metrics whereas proactive e-services. Collaboratively administrate empowered markets via plug-and-play networks. Dynamically procrastinate B2C users after installed base benefits.
EU MDR transition extension
May 9, 2023
EU MDR transition extension
The TGA recently implemented an EU MDR transition strategy for Australian medical device sponsors and stakeholders. More recently, the EU extended the transition, prompting the TGA to review its strategy, and to review the impact on reclassification reforms underway in Australia.
Register medical devices to place on the market
May 9, 2023
Register medical devices to place on the market
How to register your medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) for the markets in Great Britain and Northern Ireland
Guidance on qualified person responsible for pharmacovigilance (QPPV) including pharmacovigilance system master files (PSMF)
May 5, 2023
Guidance on qualified person responsible for pharmacovigilance (QPPV) including pharmacovigilance system master files (PSMF)
Quickly coordinate e-business applications through revolutionary catalysts for change. Seamlessly underwhelm optimal testing procedures processes. Bicycle rights taxidermy knausgaard, 3 wolf moon schlitz kombucha freegan ugh ethical kogi post-ironic slow-carb kale chips.
bt_bb_section_bottom_section_coverage_image

Our Team

Meet our team of Industry Experts
https://heliovigil.com/wp-content/uploads/2023/05/1-850x1080.jpg

Sumeet Malik

https://heliovigil.com/wp-content/uploads/2023/05/2-850x1080.jpg

Shane Hodges

https://heliovigil.com/wp-content/uploads/2023/06/Untitled-850-×-1080-px-1.png

Shruti Verma

bt_bb_section_bottom_section_coverage_image